Valérie Petit
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Valérie Petit has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Lionel Larue
INSERM U1021 and INSERM U1186 Normal and Pathological Development of Melanocytes. Institut Curie, PSL Research University, Orsay, France
10 shared publications - Zackie Aktary
INSERM U1021 and INSERM U1186 Normal and Pathological Development of Melanocytes. Institut Curie, PSL Research University, Orsay, France
9 shared publications - Véronique Delmas
Normal and Pathological Development of Melanocytes, Institut Curie, PSL Research University, INSERM U1021, Orsay, France
6 shared publications - Jeremy H. Raymond
INSERM U1021 and INSERM U1186 Normal and Pathological Development of Melanocytes. Institut Curie, PSL Research University, Orsay, France
5 shared publications - Pierre Sohier
Department of Pathology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, AP-HP.Centre-Université Paris Cité, Paris, France; and
4 shared publications - Evelyne Sage
INSERM U1021 and INSERM U1186 Normal and Pathological Development of Melanocytes. Institut Curie, PSL Research University, Orsay, France
3 shared publications
Latest Publications
- Open Access
BRN2 suppresses stress-induced hair greying
Adult stem cells maintain tissue homeostasis and regenerative capacity, but mechanisms preserving their integrity under stress remain incompletely understood. Here, we identify BRN2 (POU3F2), a POU-domain transcription factor, as a regulator of melanocyte lineage homeostasis and response to genotoxic stress. Single-cell transcriptomic analyses identified Brn2 among transcription factors preferentially active in melanocyte stem cells (McSCs), with BRN2 activity declining with age in human hair follicle melanocytic cells. Melanocyte-specific Brn2 deletion increased melanocyte differentiation and accumulation in the hair bulb, while downregulating DNA-repair and chromosome-maintenance programs. Despite these changes, Brn2 loss caused neither spontaneous hair greying nor detectable McSC depletion under steady-state conditions. Following ionizing radiation, however, Brn2 -deficient cells showed altered DNA-damage responses, reduced mitotic signatures, increased p53 and p21, and enhanced melanocytic differentiation. Irradiated Brn2 -deficient mice developed rapid, dose-dependent, permanent hair depigmentation associated with McSC and melanocyte depletion. Thus, BRN2 links POU-dependent transcriptional control to stem-cell resilience under genotoxic stress, preserving melanocyte regenerative capacity and protecting against irradiation-induced hair greying.
Open AccessBRN2 suppresses stress-induced hair greying
Adult stem cells maintain tissue homeostasis and regenerative capacity, but mechanisms preserving their integrity under stress remain incompletely understood. Here, we identify BRN2 (POU3F2), a POU-domain transcription factor, as a regulator of melanocyte lineage homeostasis and response to genotoxic stress. Single-cell transcriptomic analyses identified Brn2 among transcription factors preferentially active in melanocyte stem cells (McSCs), with BRN2 activity declining with age in human hair follicle melanocytic cells. Melanocyte-specific Brn2 deletion increased melanocyte differentiation and accumulation in the hair bulb, while downregulating DNA-repair and chromosome-maintenance programs. Despite these changes, Brn2 loss caused neither spontaneous hair greying nor detectable McSC depletion under steady-state conditions. Following ionizing radiation, however, Brn2 -deficient cells showed altered DNA-damage responses, reduced mitotic signatures, increased p53 and p21, and enhanced melanocytic differentiation. Irradiated Brn2 -deficient mice developed rapid, dose-dependent, permanent hair depigmentation associated with McSC and melanocyte depletion. Thus, BRN2 links POU-dependent transcriptional control to stem-cell resilience under genotoxic stress, preserving melanocyte regenerative capacity and protecting against irradiation-induced hair greying.
- 14 August 2026
- Published by Springer Nature in Cell Death & Differentiation
- p. 1-16
MICAL2 as a key effector of β-catenin signaling driving melanoma progression and therapeutic resistance
β-catenin plays a pivotal role in oncogenesis through its involvement in cell-cell adhesion, Wnt signaling, and transcriptional regulation. Dysregulation of β-catenin contributes to tumorigenesis by promoting proliferation, bypassing senescence, and enhancing migration and invasion. In melanoma, however, its role has been controversial, with studies reporting conflicting effects on proliferation, metastasis, and patient survival. Here, we demonstrate that activation of β-catenin is associated with a poor prognosis in melanoma. This conclusion is based on immunohistochemical analysis of a cohort of 157 patients and the identification of a genetic signature for melanoma upon β-catenin activation. This signature includes known targets such as APCDD1 and AXIN2, as well as previously unknown targets like MICAL2 and SLC1A5. Notably, MICAL2 (Molecule Interacting with CasL 2) emerged as a key regulator of the invasive phenotype, with high expression levels correlating with adverse outcomes. Functional studies confirmed that MICAL2 is transcriptionally regulated by β-catenin. Nras and Braf mouse melanoma models further validated the conserved regulation of MICAL2 by β-catenin, linking it to melanoma initiation and metastasis. Moreover, MICAL2 expression is enriched in melanoma cells resistant to BRAF inhibitors, and MICAL2 downregulation restores therapeutic sensitivity. These findings highlight MICAL2 as a central effector of β-catenin signaling and a mediator of melanoma progression and resistance. Given the therapeutic challenges of directly targeting β-catenin, inhibiting the enzymatic activity of MICAL2 offers a promising and innovative strategy to improve outcomes in β-catenin–driven melanoma.
- 14 August 2026
- Published by Springer Nature in Cell Death & Differentiation
- p. 1-16
MICAL2 as a key effector of β-catenin signaling driving melanoma progression and therapeutic resistance
β-catenin plays a pivotal role in oncogenesis through its involvement in cell-cell adhesion, Wnt signaling, and transcriptional regulation. Dysregulation of β-catenin contributes to tumorigenesis by promoting proliferation, bypassing senescence, and enhancing migration and invasion. In melanoma, however, its role has been controversial, with studies reporting conflicting effects on proliferation, metastasis, and patient survival. Here, we demonstrate that activation of β-catenin is associated with a poor prognosis in melanoma. This conclusion is based on immunohistochemical analysis of a cohort of 157 patients and the identification of a genetic signature for melanoma upon β-catenin activation. This signature includes known targets such as APCDD1 and AXIN2, as well as previously unknown targets like MICAL2 and SLC1A5. Notably, MICAL2 (Molecule Interacting with CasL 2) emerged as a key regulator of the invasive phenotype, with high expression levels correlating with adverse outcomes. Functional studies confirmed that MICAL2 is transcriptionally regulated by β-catenin. Nras and Braf mouse melanoma models further validated the conserved regulation of MICAL2 by β-catenin, linking it to melanoma initiation and metastasis. Moreover, MICAL2 expression is enriched in melanoma cells resistant to BRAF inhibitors, and MICAL2 downregulation restores therapeutic sensitivity. These findings highlight MICAL2 as a central effector of β-catenin signaling and a mediator of melanoma progression and resistance. Given the therapeutic challenges of directly targeting β-catenin, inhibiting the enzymatic activity of MICAL2 offers a promising and innovative strategy to improve outcomes in β-catenin–driven melanoma.
- Open Access
- 15 November 2024
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 137 (22)
UVB radiation suppresses Dicer expression through β-catenin
Ultraviolet (UV) rays prompt a natural response in epidermal cells, particularly within melanocytes. The changes in gene expression and related signaling pathways in melanocytes following exposure to UV radiation are still not entirely understood. Our findings reveal that UVB irradiation suppresses the expression of Dicer (also known as Dicer1). This repression is intricately linked to the activation of the phosphoinositide 3-kinase (PI3K), ribosomal S6 kinase (RSK) and Wnt–β-catenin signaling pathways, and is directly associated with transcriptional repression by β-catenin (also known as CTNNB1). Notably, we have identified specific binding sites for the TCF/LEF–β-catenin complex in the Dicer promoter. Collectively, these results emphasize the significance of the UV-induced pathway involving the TCF/LEF–β-catenin complex, which impacts Dicer expression. UV radiation also reduced the levels of specific microRNAs known to be important in the biology of melanocytes. This pathway holds potential importance in governing melanocyte physiology.
- 15 November 2024
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 137 (22)
Open AccessUVB radiation suppresses Dicer expression through β-catenin
Ultraviolet (UV) rays prompt a natural response in epidermal cells, particularly within melanocytes. The changes in gene expression and related signaling pathways in melanocytes following exposure to UV radiation are still not entirely understood. Our findings reveal that UVB irradiation suppresses the expression of Dicer (also known as Dicer1). This repression is intricately linked to the activation of the phosphoinositide 3-kinase (PI3K), ribosomal S6 kinase (RSK) and Wnt–β-catenin signaling pathways, and is directly associated with transcriptional repression by β-catenin (also known as CTNNB1). Notably, we have identified specific binding sites for the TCF/LEF–β-catenin complex in the Dicer promoter. Collectively, these results emphasize the significance of the UV-induced pathway involving the TCF/LEF–β-catenin complex, which impacts Dicer expression. UV radiation also reduced the levels of specific microRNAs known to be important in the biology of melanocytes. This pathway holds potential importance in governing melanocyte physiology.
- Open Access
UVB radiation suppresses Dicer expression through β-catenin
Ultraviolet (UV) rays prompt a natural response in epidermal cells, particularly within melanocytes. The changes in gene expression and related signaling pathways in melanocytes following exposure to UVR are still not entirely understood. Our findings reveal that UVB irradiation suppresses the expression of Dicer. This repression is intricately linked to the activation of the PI3K, RSK, and WNT/β-catenin signaling pathways and is directly associated with transcriptional repression by β-catenin. Notably, we have identified specific binding sites for the LEF/β-catenin complex in the Dicer promoter. Collectively, these results emphasize the significance of the UV-induced pathway involving LEF/β-catenin, which impacts Dicer expression. This pathway holds potential importance in governing melanocyte physiology.
Open AccessUVB radiation suppresses Dicer expression through β-catenin
Ultraviolet (UV) rays prompt a natural response in epidermal cells, particularly within melanocytes. The changes in gene expression and related signaling pathways in melanocytes following exposure to UVR are still not entirely understood. Our findings reveal that UVB irradiation suppresses the expression of Dicer. This repression is intricately linked to the activation of the PI3K, RSK, and WNT/β-catenin signaling pathways and is directly associated with transcriptional repression by β-catenin. Notably, we have identified specific binding sites for the LEF/β-catenin complex in the Dicer promoter. Collectively, these results emphasize the significance of the UV-induced pathway involving LEF/β-catenin, which impacts Dicer expression. This pathway holds potential importance in governing melanocyte physiology.
- Open Access
- 21 September 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (3) , 601-611
Loss of Dicer in Newborn Melanocytes Leads to Premature Hair Graying and Changes in Integrin Expression
- 21 September 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (3) , 601-611
Open AccessLoss of Dicer in Newborn Melanocytes Leads to Premature Hair Graying and Changes in Integrin Expression
- 21 March 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (4) , 538-544.e2
Derivation and Use of Cell Lines from Mouse Models of Melanoma
- 21 March 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (4) , 538-544.e2
Derivation and Use of Cell Lines from Mouse Models of Melanoma
- 21 March 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (4) , A3-A5
Table of Contents
- 21 March 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (4) , A3-A5
Table of Contents
- Open Access
The E-cadherin-ESR1-GRPR axis defines a sex-specific metastatic pathway in melanoma
Summary: Although tremendous progress has been made in understanding the mechanisms leading to cancer, those governing metastases are still poorly understood. E-cadherin (Ecad) is a cell-cell adhesion molecule essential for tissue homeostasis, and its loss often correlates with the dissemination of human cancers. However, whether and how the loss of Ecad triggers the full metastatic program is largely unknown. Here, we show that the loss of Ecad promotes melanoma lung metastases in females. The loss of Ecad, after the induction of estrogen receptor α (ERα) expression, activates gastrin-releasing peptide receptor (GRPR) expression. GRPR promotes cellular processes essential for metastasis formation through G□ q and YAP1 signaling and its pharmacological inhibition reduces metastasis in vivo . This study reveals an Ecad-ERα-GRPR metastatic sex dimorphism axis in melanoma that is conserved in human breast cancer and provides proof of concept that the G-coupled receptor GRPR is a therapeutic target for metastasis.
Open AccessThe E-cadherin-ESR1-GRPR axis defines a sex-specific metastatic pathway in melanoma
Summary: Although tremendous progress has been made in understanding the mechanisms leading to cancer, those governing metastases are still poorly understood. E-cadherin (Ecad) is a cell-cell adhesion molecule essential for tissue homeostasis, and its loss often correlates with the dissemination of human cancers. However, whether and how the loss of Ecad triggers the full metastatic program is largely unknown. Here, we show that the loss of Ecad promotes melanoma lung metastases in females. The loss of Ecad, after the induction of estrogen receptor α (ERα) expression, activates gastrin-releasing peptide receptor (GRPR) expression. GRPR promotes cellular processes essential for metastasis formation through G□ q and YAP1 signaling and its pharmacological inhibition reduces metastasis in vivo . This study reveals an Ecad-ERα-GRPR metastatic sex dimorphism axis in melanoma that is conserved in human breast cancer and provides proof of concept that the G-coupled receptor GRPR is a therapeutic target for metastasis.
- 6 September 2022
- Published by Morressier GmbH
ESDR477 - POU3F2 is a non-canonical tumor suppressor for melanoma
While the main drivers of melanoma initiation, including NRAS/BRAF activation and loss of PTEN or CDKN2A, have been identified, the role of key t | POSTER
- 6 September 2022
- Published by Morressier GmbH
ESDR477 - POU3F2 is a non-canonical tumor suppressor for melanoma
While the main drivers of melanoma initiation, including NRAS/BRAF activation and loss of PTEN or CDKN2A, have been identified, the role of key t | POSTER
- 1 February 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (2) , 425-434
CLEC12B Decreases Melanoma Proliferation by Repressing Signal Transducer and Activator of Transcription 3
- 1 February 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (2) , 425-434
CLEC12B Decreases Melanoma Proliferation by Repressing Signal Transducer and Activator of Transcription 3